Publications
- Pros and Cons of Portal Vein Embolization With Hematopoietic Stem Cells Application in Colorectal Liver Metastases Surgery2020 | Faculty of Medicine in Pilsen
- Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma2019 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization2019 | Faculty of Medicine in Pilsen
- lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Experimental promotion of liver regeneration after portal vein branch ligation2018 | Faculty of Medicine in Pilsen
- Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases2018 | Faculty of Medicine in Pilsen
- Experimental liver regeneration2018 | Faculty of Medicine in Pilsen
- The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases2017 | Faculty of Medicine in Pilsen
- Portal Vein Embolisation with Application of Haematopoietic Stem Cells in Patients with Primarily or Non-resectable Colorectal Liver Metastases2014 | Faculty of Medicine in Pilsen
Loading network view...